Orchestra BioMed Holdings, Inc. (OBIO) Gross margin 2022–2025
Orchestra BioMed Holdings, Inc. (OBIO) gross margin by fiscal year — reported gross profit divided by reported revenue.
99.4%FY2025 · since FY2022: 94.0% → 99.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 99.4% | +7.2 pp |
| FY2024 | 92.3% | -1.0 pp |
| FY2023 | 93.3% | -0.8 pp |
| FY2022 | 94.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice